Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 501 - 550 out of 2,527

Document Document Title
WO/2002/058690A2
The present invention relates to methods for the prophylaxis, management and treatment of certain diseases modulated by the inhibition of the enzyme malonyl-coenzyme A decarboxylase (malonyl-CoA decarboxylase, MCD) by the administration ...  
WO/2002/053090A2
The invention concerns a medicinal combination, for treating diabetes, in particular type 2 diabetes, associating a biguanine, in particular a N-dimethylbiguanine, as first medicine, and a carrier agent for said biguanine, as second medi...  
WO/2002/052957A1
The invention relates to addition and/or co-ordination compounds consisting of creatine and citric acid in the ratio of >1.0 to 3.0: 1.0. Said compounds are characterised in that they have (KBr) bands in the IR spectrum, where $g(n)= 342...  
WO/2002/036554A2
Novel amidino-urea 5-HT¿7? receptor ligands, methods of preparing such ligands, intermediate compounds useful in the preparation of the receptor ligands, pharmaceutical compositions comprising the receptor ligands, and methods of treati...  
WO/2002/032392A1
Skin pore minimizers containing as the active ingredient compounds of the following general formula: R?1¿-OG or salts thereof [wherein R?1¿ is C¿8-32? alkyl or alkenyl; and OG is a residue derived from a polyhydric alcohol, a monosacc...  
WO/2002/030877A1
The invention relates to chemistry, in particular to the production of disinfectants which are based on polyalkylene guanidines and polyoxialkylene guanidines and can be used as environmentally safe and efficient disinfectants for medici...  
WO/2002/028825A2
Phenyl acetamide compounds are described, including compounds of Formula (I): or a solvate, hydrate or pharmaceutically acceptable salt thereof; wherein R?3¿-R?6¿, R?11¿, B, Y and W are set forth in the specification. The compounds of...  
WO2000063193A9
This invention relates to novel polymorphic/pseudopolymorphic forms of arginine salt of 3-[4-[2-(phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropanoic acid, having formula (I). The invention also relates to a pharmaceutical composition compr...  
WO/2002/022626A1
Provided herein are novel and useful combretastatin A-4 prodrug salts that increase the solubility of combretastatin A-4, readily regenerate combretastatin A-4 in vivo under normal physiological conditions, and which produce physiologica...  
WO/2002/022553A2
This invention relates to positively charged non-natural amino acids, methods of making thereof, and utilization thereof in peptides.  
WO/2002/022135A1
The present invention describes a method for providing creatine to an animal which includes receiving a creatine ester by the animal. The creatine ester is suitable for being modified by the animal to form creatine.  
WO/2002/020475A2
The present invention provides compounds which inhibit serine protease activity of matriptase or MTSP1. Also provided are pharmaceutical compositions comprising those compounds and methods of using the compounds and pharmceutical composi...  
WO/2002/018327A2
Compounds of formula (IA) and (IB) are new where the variables R?1¿ through R?10¿ have the values set forth herein. Such compounds have use in treating diseases such as obesity and type II diabetes, and may be provided as pharmaceutica...  
WO/2002/016318A1
The present invention relates to novel thiourea derivatives as a modulator for vanilloid receptor (VR) and the pharmaceutical compositions containing the same. As diseases associated with the activity of vanilloid receptor, pain acute pa...  
WO/2002/014329A1
Compositions for the inhibition of the formation of new vaculature by angiogenesis are provided as in compounds which are salts comprising as an acidic component a compound of formula (1) wherein: R?1¿, R?2¿ and R?3¿ are each independ...  
WO/2002/012166A2
The invention provides triamine derivative melanocortin receptor ligands of the formula (1), wherein R?1¿ to R?8¿ and n have the meanings provided herein. The invention further provides methods of using the ligands to alter or regulate...  
WO/2002/012177A1
This invention relates to compositions comprising metformin and succinic acid or a pharmaceutically acceptable salt thereof. More specifically, this invention relates to compositions comprising metformin and succinic acid or a pharmaceut...  
WO/2002/012168A1
A compound having general formula (I) and methods of using such compounds for the treatment of diseases and pharmaceutical composition comprising such compounds.  
WO/2002/008175A2
Arginine saccharate and its use in the prevention and treatment of cardiovascular and circulatory disorders such as atherosclerosis and hypertension. The compound is synthesized by mixing arginine with a salt of saccharic acid. Pharmaceu...  
WO/2002/004406A2
The present invention pertains, at least in part, to novel 9- substituted minocycline compounds. These minocyline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms...  
WO/2002/000614A1
The present invention relates to compounds of the formula (I) wherein X is selected from O, S, SO, SO¿2?, NR, CR¿2?, C(OH)R and C=O; each R?1¿ is independently selected from H, C¿1-12?alkyl and C¿3-12?aryl; R?2¿ is selected from H,...  
WO/2001/098235A2
The invention relates to 3,4-dihydroxybenzyl-substituted carbonic acid derivatives, to their production, and to their use as antioxidants or free-radical scavengers, especially in cosmetic and pharmaceutical preparations and in foodstuff...  
WO/2001/096281A1
Double fumarates of L-carnitine or isovaleryl L-carnitine and an amino acid are disclosed which are useful as active ingredients of food supplements, dietary supplements or drugs.  
WO/2001/094292A1
The invention concerns the preparation of cationic surfactants derived from the condensation of an acid, preferably a fatty acid or a hydroxy acid with a number of carbon atoms of 8 - 14 with esterified amino acids, preferably basic-type...  
WO/2001/092207A1
A process of reacting a compound having an NH group with a thiocyanate, a cyanamide, a nitrile, or an ester in the presence of a silylating agent to thereby obtain the corresponding nitrogen-containing addition or substitution product. T...  
WO/2001/092210A1
This invention provides certain compounds, methods of their preparation, pharmaceutical compositions comprising the compounds, their use in treating human or animal disorders. The compounds of the invention are useful as modulators of th...  
WO/2001/092218A2
Novel 'bispolyamine' inhibitor compounds of polyamine transport are disclosed. These compounds are useful pharmaceutical agents for treating diseases where it is desired to inhibit polyamine transport or other polyamine binding proteins,...  
WO/2001/087840A1
Novel propanoic acid derivatives are integrin receptor antagonists or inhibitors, in particular of the avb3 integrin receptor. The compounds of the invention are for instance useful for the treatment of solid tumors by inhibition of angi...  
WO/2001/087829A1
The invention relates to bisacylguanidine of formula (I), wherein one of radicals is R?1¿, R?2¿, R?3¿, R?4¿, or R?5¿ and one of the radicals is R?6¿, R?7¿, R?8¿, R?9¿ or R?10¿, and to its physiologically acceptable salts and/or...  
WO/2001/085728A2
The present invention relates to optically pure 8-(substituted piperidino)-benzo [i,j] quinolizines, their isomers, derivatives, salts, pseudopolymorphs, polymorphs prodrugs and hydrates thereof, to processes for their preparation, and t...  
WO/2001/086057A1
The invention relates to an agent for coloring fibers, which is prepared before use by mixing an acidic component (A1), which contains at least one enamine of formula (I)/(Ia), with a component (A2), which contains a Schiff's base of for...  
WO/2001/085676A1
The invention relates to biocidal polymers with a guanidine salt base, characterised in that they are representatives of the series of polyoxyalkylene guanidines and their salts and in that they represent a product of the polycondensatio...  
WO/2001/085677A1
The invention concerns novel amino acid derivatives and their use as medicines. Said derivatives have an inhibiting activity towards NO-synthase enzymes producing nitrogen monoxide NO and/or (optionally): either an activity trapping reac...  
WO/2001/083429A1
Compounds represented by the formular (A), tautomers thereof, or medicinally acceptable salts of both exhibit an NOS-inhibitory activity and are useful as drugs in the treatment of various diseases.  
WO/2001/079359A2
Anti-fouling agents comprising isothiouronium salts, guanidinium salts, and their conjugate base analogs are provided. Anti-fouling coating compositions that include these anti-fouling agents are also provided. Such anti-fouling agents a...  
WO/2001/072701A1
A ceramide derivative of the formula (I).  
WO/2001/070204A2
The invention relates to novel selective inhibitors of the urokinase plasminogen activator (uPA, EC 3.4.21.31), of the arylguanidine type.  
WO/2001/062735A1
The present invention relates to new compounds for the inhibition of blood clotting proteins, and more particularly, to malonic acid derivatives of the formula (I), wherein R(1), R(2), R(3), R(4), R(5), and R(6) have the meanings indicat...  
WO/2001/062242A1
A compound represented by the formulae (A) or (B) wherein R¿1? is H, R¿5?, (a), (b), (c), (d), (e), (f), (g), — (CH¿2?)¿n?OC(O)R¿5?, —(CH¿2?)¿n?OR¿5?, or —(CH¿2?)¿n?-N-R¿6?; each R¿2? and R¿3? individually is H, (CH¿2...  
WO/2001/058860A1
The invention concerns novel arginine-derived surface active compounds consisting of monoacyl glycerides and diacyl glycerides of general formula (I) and designed to act as surface active agents with antimicrobial activity. The activity ...  
WO/2001/058859A1
The invention generally relates to a novel kind of arginine mimetics which are inhibitors of the factor X¿a?. The invention also relates to pharmaceutical compositions that contain said mimetics and to the use of said arginine mimetics ...  
WO/2001/056975A1
The invention concerns novel substituted imide derivatives of general formula (I), wherein R?1¿ represents optionally substituted cycloalkyl; R?2¿ represents optionally substituted alkyl or optionally substituted cycloalkyl; R?3¿ repr...  
WO/2001/055107A2
The present invention relates to novel aromatic amines and amides of general formula (I) and to the use of these amines and amides for the treatment of obesity, anorexia, inflammation, mental disorders and other diseases associated with ...  
WO/2001/055098A1
The present invention is directed to a compound having the structure (I): and acceptable salts, polypeptides, and pro-forms thereof, wherein R is selected from the group consisting of: (a) substituted glycerols; wherein n is an integer f...  
WO/2001/055111A1
The invention relates to biaryl compounds, their preparation and their use in the treatment of bacterial and viral infection.  
WO/2001/055099A1
The invention relates to a method for producing 1-methyl-3-nitroguanidine. According to said method, nitroguanidine is reacted with methylamine and/or a methylammonium salt in an aqueous solution, at temperatures of 30 to 60 °C and at a...  
WO/2001/053276A1
A compound of formula (I) or (II), wherein X is hydrogen, halogen, alkyl, aralkyl,aryloxy, arylalkoxy or alkoxy, Y is hydrogen, halogen, alkyl, aralkyl, aryloxy, arylalkoxy or alkoxy, or formula (a) wherein A and B are different and one ...  
WO/2001/053201A1
A family of borate compounds containing an isolated (finite) nonaborate anion with the structural formula [B¿9?O¿12?(OH)¿6?]?3-¿. Preferred amine nonaborate compounds have a resolved oxide formula of A¿2?O.3B¿2?O¿3?.2H¿2?O, where...  
WO/2001/051458A1
The invention relates to a novel method for producing N-methyl-N'-nitroguanidine by reacting nitroguanidine with an aqueous methylamine solution that has been buffered by adding inorganic or organic acids.  
WO/2001/049721A2
The present invention provides novel bacterial genes and their encoded polypeptides thereof which are essential for bacterial cell viability, and their uses.  

Matches 501 - 550 out of 2,527